Niacin (Page 7 of 7)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1
(click image for full-size original)

NDC 50268-584-13
Niacin Extended-Release Tablets
500 mg
Rx Only
30 Tablets (3 x 10) Unit Dose
5026858413
NDC 50268-584-13
Niacin Extended-Release Tablets
500 mg
Rx Only
30 Tablets (3 x 10) Unit Dose
5026858413
Pharmacist: Please dispense with Patient Information Leaflet provided separately.
Each film-coated extended-release tablet contains:
Niacin, USP…….. 500 mg
Usual Dosage: See package insert for full prescribing
information.
Store at 20° to 25°C (68° to 77°F) [See USP
Controlled Room Temperature].
KEEP THIS AND ALL MEDICATION OUT OF THE
REACH OF CHILDREN.
Manufactured for:
AvKARE, Inc.
Pulaski, TN 38478
AvPAK
A Product of AvKARE
Mfg. Rev. 07-2015-11
AV 09/17 (P) Niacin Extended-Release Tablets 500 mg Rx Only 30 Tablets (3 x 10) Unit Dose 5026858413

2
(click image for full-size original)

NDC 50268-586-13
Niacin Extended-Release Tablets
1000 mg
Rx Only
30 Tablets (3 x 10) Unit Dose
5026858613
NDC 50268-586-13
Niacin Extended-Release Tablets
1000 mg
Rx Only
30 Tablets (3 x 10) Unit Dose
5026858613
Pharmacist: Please dispense with Patient Information
Leaflet provided separately.
Each film-coated extended-release tablet contains:
Niacin, USP ………………………………………. 1000 mg
Usual Dosage: See package insert for full prescribing
information.
Store at 20° to 25°C (68° to 77°F) [See USP
Controlled Room Temperature].
KEEP THIS AND ALL MEDICATION OUT OF THE
REACH OF CHILDREN.
Manufactured for:
AvKARE, Inc.
Pulaski, TN 38478
AvPAK
A Product of AvKARE
Mfg. Rev. 07-2015-01 AV 09/17 (P)

NIACIN niacin tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50268-584(NDC:65162-321)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
NIACIN (NIACIN) NIACIN 500 mg
Inactive Ingredients
Ingredient Name Strength
FD&C YELLOW NO. 6
HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%)
HYPROMELLOSES
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
POLYETHYLENE GLYCOL 400
STEARIC ACID
TITANIUM DIOXIDE
Product Characteristics
Color orange Score no score
Shape ROUND Size 11mm
Flavor Imprint Code AN;321
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50268-584-13 30 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (50268-584-11)
1 NDC:50268-584-11 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (50268-584-13)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203578 09/14/2017
NIACIN niacin tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50268-586(NDC:65162-323)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
NIACIN (NIACIN) NIACIN 1000 mg
Inactive Ingredients
Ingredient Name Strength
FD&C YELLOW NO. 6
HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%)
HYPROMELLOSES
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
POLYETHYLENE GLYCOL 400
STEARIC ACID
TITANIUM DIOXIDE
Product Characteristics
Color orange Score no score
Shape CAPSULE Size 19mm
Flavor Imprint Code AN;323
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50268-586-13 30 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (50268-586-11)
1 NDC:50268-586-11 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (50268-586-13)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203578 09/14/2017 09/30/2021
Labeler — AvPAK (832926666)

Revised: 10/2021 AvPAK

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.